Study: Prazosin inhibits endocytic sorting

September 13, 2012

In a study just published in Proceedings of the National Academy of Sciences, Dr Ulrike Eggert et al. demonstrated that the drug Prazosin inhibits endocytic sorting.

They implicate the G protein-coupled dopamine receptor D3 and the membrane transport complex coatomer COPI in this process, proposing  a new biological role for .

This work shows an interesting off-target effect of Prazosin, used in the clinic as an antagonist of α1-adrenic receptors (a sub-family of G ), providing a useful tool for the further study of endosome dynamics.

Explore further: Review: Blood pressure drug effective for treating PTSD-related nightmares

More information: www.pnas.org/content/109/31/12485.full.pdf+html

Related Stories

Recommended for you

Male hormone reverses cell aging in clinical trial

July 26, 2016

Telomerase, an enzyme naturally found in cells, is often described as a "cellular elixir of youth." In a recent study, Brazilian and U.S. researchers show that sex hormones can stimulate production of this enzyme.

Promising new drug could help treat spinal muscular atrophy

July 25, 2016

According to studies, approximately one out of every 40 individuals in the United States is a carrier of the gene responsible for spinal muscular atrophy (SMA), a neurodegenerative disease that causes muscles to weaken over ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.